Literature DB >> 12933953

Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A.

F Brancati1, E M Valente, N P Davies, A Sarkozy, M G Sweeney, M LoMonaco, A Pizzuti, M G Hanna, B Dallapiccola.   

Abstract

The authors describe an Italian kindred with nine individuals affected by hyperkalaemic periodic paralysis associated with paramyotonia congenita (hyperPP/PMC). Periodic paralysis was particularly severe, with several episodes a day lasting for hours. The onset of episodes was unusually early, beginning in the first year of life and persisting into adult life. The paralytic episodes were refractory to treatment. Patients described minimal paramyotonia, mainly of the eyelids and hands. All affected family members carried the threonine to methionine substitution at codon 704 (T704M) in exon 13 of the skeletal muscle voltage gated sodium channel gene (SCN4A). The association between T704M and the hyperPP/PMC phenotype has been only recently revealed. Nevertheless, such a severe phenotype has never been reported so far in families with either hyperPP or hyperPP/PMC. These data further broaden the clinical spectrum of T704M and support the evidence that this mutation is a common cause of hyperPP/PMC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933953      PMCID: PMC1738672          DOI: 10.1136/jnnp.74.9.1339

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

Review 1.  Sodium Channelopathies of Skeletal Muscle.

Authors:  Stephen C Cannon
Journal:  Handb Exp Pharmacol       Date:  2018

Review 2.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 3.  Mutations of Voltage-Gated Ionic Channels and Risk of Severe Cardiac Arrhythmias.

Authors:  Amir Dehghani-Samani; Samin Madreseh-Ghahfarokhi; Azam Dehghani-Samani
Journal:  Acta Cardiol Sin       Date:  2019-03       Impact factor: 2.672

4.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

5.  Familial hyperkalemic periodic paralysis caused by a de novo mutation in the sodium channel gene SCN4A.

Authors:  Ji-Yeon Han; June-Bum Kim
Journal:  Korean J Pediatr       Date:  2011-11-30

6.  A Large Dominant Myotonia Congenita Family with a V1293I Mutation in SCN4A.

Authors:  Ki Wha Chung; Da Hye Yoo; Soo Jung Lee; Byung Ok Choi; Sang Soo Lee
Journal:  J Clin Neurol       Date:  2016-07-26       Impact factor: 3.077

7.  Measuring quality of life impairment in skeletal muscle channelopathies.

Authors:  V A Sansone; C Ricci; M Montanari; G Apolone; M Rose; G Meola
Journal:  Eur J Neurol       Date:  2012-05-19       Impact factor: 6.089

8.  Identification of a SCN4A mutation in a large Chinese family with atypical normokalemic periodic paralysis using whole-exome sequencing.

Authors:  XinYu Tan; SongNian Hu; Zongyu Xie; Hailiang Mei; Yang Liu; Liang Yin; Peng Shi; Qiming Chen; Daoqian Sang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.